Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed
Permanent URI for this communityhttps://hdl.handle.net/20.500.14719/1741
Browse
475 results
Search Results
Publication Metadata only Sport marketing and social media strategies A literature review and research agenda(ROUTLEDGE, 2022) Zeren, Deniz; Erkan, Ismail; Acikgoz, Fulya; Zhang, JJ; Crabtree, RM; Cukurova University; Izmir Katip Celebi University; Bahcesehir University; Istanbul Technical UniversityPublication Metadata only Response to My Criticism Article Titled The Claim That the Edirne Badi Efendi Chronicle Is the 'First Anonymous Chronicle' and Some Considerations on Negri(ISTANBUL 29 MAYIS UNIV & ISAM, 2024) Ozturk, Necdet; Bahcesehir UniversityPublication Metadata only Some Considerations on the Publication of the Edirne Badi Efendi Copy with the Claim that it is the 'First Anonymous Chronicle'(ISTANBUL 29 MAYIS UNIV & ISAM, 2023) Ozturk, Necdet; Bahcesehir UniversityPublication Metadata only Whither Defterology? A Review Article of Halil Inalcik, Evgeni Radushev & Ugur Altug, 1445 Tarihli Pasa Livasi Icmal Defteri(ISTANBUL 29 MAYIS UNIV & ISAM, 2023) Lowry, Heath W.; Bahcesehir UniversityPublication Metadata only A Review of Recent Studies on the Antioxidant and Anti-Infectious Properties of Senna Plants(WILEY, 2022) Alshehri, Mohammed M.; Quispe, Cristina; Herrera-Bravo, Jesus; Sharifi-Rad, Javad; Tutuncu, Sena; Aydar, Elif Feyza; Topkaya, Cansu; Mertdinc, Zehra; Ozcelik, Beraat; Aital, Mahima; Kumar, N. V. Anil; Lapava, Natallia; Rajkovic, Jovana; Ertani, Andrea; Nicola, Silvana; Semwal, Prabhakar; Painuli, Sakshi; Gonzalez-Contreras, Carlos; Martorell, Miquel; Butnariu, Monica; Bagiu, Iulia Cristina; Bagiu, Radu Vasile; Barbhai, Mrunal D.; Kumar, Manoj; Dastan, Sevgi Durna; Calina, Daniela; Cho, William C.; King Saud Bin Abdulaziz University for Health Sciences; Ministry of National Guard - Health Affairs; Universidad Arturo Prat; Universidad Santo Tomas; Universidad de La Frontera; Universidad del Azuay; Istanbul Technical University; Bahcesehir University; Manipal Academy of Higher Education (MAHE); Grodno State Medical University; University of Belgrade; University of Turin; Graphic Era University; Universidad de Concepcion; Universidad de Concepcion; Victor Babes University of Medicine & Pharmacy, Timisoara; Cumhuriyet University; Cumhuriyet University; University of Medicine & Pharmacy of CraiovaThe use of phytochemicals is gaining interest for the treatment of metabolic syndromes over the synthetic formulation of drugs. Senna is evolving as one of the important plants which have been vastly studied for its beneficial effects. Various parts of Senna species including the root, stem, leaves, and flower are found rich in numerous phytochemicals. In vitro, in vivo, and clinical experiments established that extracts from Senna plants have diverse beneficial effects by acting as a strong antioxidant and antimicrobial agent. In this review, Senna genus is comprehensively discussed in terms of its botanical characteristics, traditional use, geographic presence, and phytochemical profile. The bioactive compound richness contributes to the biological activity of Senna plant extracts. The review emphasizes on the in vivo and in vitro antioxidant and anti-infectious properties of the Senna plant. Preclinical studies confirmed the beneficial effects of the Senna plant extracts and its bioactive components in regard to the health-promoting activities. The safety, side effects, and therapeutic limitations of the Senna plant are also discussed in this review. Additional research is necessary to utilize the phenolic compounds towards its use as an alternative to pharmacological treatments and even as an ingredient in functional foods.Publication Metadata only Exploring treatment options for pediatric refractory chronic urticaria(TAYLOR & FRANCIS LTD, 2025) Kostara, Maria; Kosmeri, Chrysoula; Kocatuerk, Emek; Alvaro-Lozano, Montserrat; Barbaud, Annick; Tsabouri, Sophia; University of Ioannina; University Hospital Ioannina; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Bahcesehir University; University of Barcelona; University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)IntroductionUrticaria is an inflammatory skin condition characterized by pruritic wheals, angioedema, or both. The global lifetime prevalence of chronic urticaria (CU) is estimated at 1.4%, with a slightly higher prevalence in children than adults. Although CU is not life-threatening, it significantly affects children's quality of life, affecting sleep, daily activities, and emotional well-being.Areas coveredWhile many cases remit over time, a subset of children experiences refractory CU, which does not respond to standard or high-dose antihistamines. Treatment follows a stepwise approach, with second-generation H1-antihistamines, including dose escalation, as the first-line therapy. Omalizumab, a monoclonal anti-IgE antibody, is recommended for antihistamine-refractory cases. Other options include cyclosporine A and short-term corticosteroids for severe exacerbations. Emerging therapies, including dupilumab, Bruton's tyrosine kinase inhibitors, and barzolvolimab, show promise for refractory cases but require further research in pediatric populations.Expert opinionA stepwise treatment approach for pediatric refractory CU is presented in this review. Given its chronic nature and treatment challenges, ongoing research is crucial to optimize management strategies and improve patient outcomes.Publication Metadata only Advanced and Smart Textiles during and after the COVID-19 Pandemic: Issues, Challenges, and Innovations(MDPI, 2023) Ivanoska-Dacikj, Aleksandra; Oguz-Gouillart, Yesim; Hossain, Gaffar; Kaplan, Muslum; Sivri, Caglar; Ros-Lis, Jose Vicente; Mikucioniene, Daiva; Munir, Muhammad Usman; Kizildag, Nuray; Unal, Serkan; Safarik, Ivo; Akgul, Esra; Yildirim, Nida; Bedeloglu, Ayse Celik; Unsal, Omer Faruk; Herwig, Gordon; Rossi, Rene M.; Wick, Peter; Clement, Pietro; Sarac, A. Sezai; Bartin University; Bahcesehir University; University of Valencia; Kaunas University of Technology; Gebze Technical University; Sabanci University; Sabanci University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Palacky University Olomouc; Erciyes University; Karadeniz Technical University; Bursa Technical University; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Istanbul Technical UniversityThe COVID-19 pandemic has hugely affected the textile and apparel industry. Besides the negative impact due to supply chain disruptions, drop in demand, liquidity problems, and overstocking, this pandemic was found to be a window of opportunity since it accelerated the ongoing digitalization trends and the use of functional materials in the textile industry. This review paper covers the development of smart and advanced textiles that emerged as a response to the outbreak of SARS-CoV-2. We extensively cover the advancements in developing smart textiles that enable monitoring and sensing through electrospun nanofibers and nanogenerators. Additionally, we focus on improving medical textiles mainly through enhanced antiviral capabilities, which play a crucial role in pandemic prevention, protection, and control. We summarize the challenges that arise from personal protective equipment (PPE) disposal and finally give an overview of new smart textile-based products that emerged in the markets related to the control and spread reduction of SARS-CoV-2.Publication Metadata only How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19(MDPI, 2023) Kocatuerk, Emek; Munoz, Melba; Elieh-Ali-Komi, Daniel; Criado, Paulo Ricardo; Peter, Jonny; Kolkhir, Pavel; Can, Pelin; Gotua, Maia; Wedi, Bettina; Rudenko, Michael; Ensina, Luis Felipe; Grattan, Clive; Maurer, Marcus; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Koc University; University of Cape Town; Bahcesehir University; Hannover Medical School; Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London; Guy's & St Thomas' NHS Foundation TrustSince more than a century ago, there has been awareness of the connection between viral infections and the onset and exacerbation of urticaria. Our knowledge about the role of viral infection and vaccination in acute and chronic urticaria improved as a result of the COVID-19 pandemic but it has also highlighted knowledge gaps. Viral infections, especially respiratory tract infections like COVID-19, can trigger the onset of acute urticaria (AU) and the exacerbation of chronic urticaria (CU). Less frequently, vaccination against viruses including SARS-CoV-2 can also lead to new onset urticaria as well as worsening of CU in minority. Here, with a particular focus on COVID-19, we review what is known about the role of viral infections and vaccinations as triggers and causes of acute and chronic urticaria. We also discuss possible mechanistic pathways and outline the unmet needs in our knowledge. Although the underlying mechanisms are not clearly understood, it is believed that viral signals, medications, and stress can activate skin mast cells (MCs). Further studies are needed to fully understand the relevance of viral infections and vaccinations in acute and chronic urticaria and to better clarify causal pathways.Publication Metadata only Combating Phytopathogens by Integration of Metagenomics and Phototrophic Biotechnologies: Toward Sustainable Agricultural Practices(TAYLOR & FRANCIS INC, 2025) Sadvakasova, Assemgul K.; Kossalbayev, Bekzhan D.; Zaletova, Dilnaz; Bauenova, Meruyert O.; Huang, Zhiyong; Zharmukhamedov, Sergey K.; Shabala, Sergey; Allakhverdiev, Suleyman I.; Al-Farabi Kazakh National University; Satbayev University; Satbayev University; Akhmet Yassawi International Kazakh-Turkish University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Russian Academy of Sciences; University of Western Australia; Timiryazev Institute of Plant Physiology; Bahcesehir UniversityRising global food demand amid climate change presents unprecedented challenges for modern agriculture. The spread of phytopathogens and the degradation of agroecosystems necessitate the development of innovative plant protection solutions. Traditional chemical pesticides are losing their effectiveness due to the emergence of resistant pathogens and their adverse environmental impacts, thereby intensifying interest in biological control methods. This study examines the integration of metagenomic analysis and phototrophic biotechnology as a promising approach to biocontrol. Metagenomics enables the precise identification of phytopathogens and beneficial microorganisms, laying the groundwork for the development of targeted biopesticides. Phototrophic microorganisms, including microalgae and cyanobacteria, exhibit antimicrobial properties and contribute to the restoration of soil ecosystems. The convergence of these technologies offers opportunities to form adaptive microbial consortia that ensure the long-term sustainability of agroecosystems. The paper discusses key challenges, including data processing complexities, the scalability of technologies, and regulatory barriers, and underscores the need for standardized methodologies and interdisciplinary collaboration. The integration of metagenomics and phototrophic biotechnology represents a promising direction for creating environmentally safe and sustainable agricultural production systems.Publication Metadata only Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak(Tubitak Scientific & Technological Research Council Turkey, 2021) Yalcinkaya, Ebru Yilmaz; Karadag Saygi, Evrim; Ozyemisci Taskiran, Ozden; Capan, Nalan; Kutlay, Sehim; Sonel Tur, Birkan; Ozlem, E. L.; Unlu Akyuz, Ece; Tekin, Suda; Ofluoglu, Demet; Zinnuroglu, Murat; Akpinar, Pinar; Ozekli Misirlioglu, Tugce; Huner, Berrin; Nur, Hakan; Caglar, Sibel; Sezgin, Melek; Tikiz, Canan; Ones, Kadriye; Icagasioglu, Afitap; Aydin, Resa; University of Health Sciences Turkey; Marmara University; Koc University; Istanbul University; Ankara University; Dokuz Eylul University; University of Health Sciences Turkey; Koc University; Bahcesehir University; Gazi University; University of Health Sciences Turkey; Fatih Sultan Mehmet Training & Research Hospital; Istanbul University - Cerrahpasa; Akdeniz University; University of Health Sciences Turkey; Mersin University; Celal Bayar University; Istanbul Physical Medicine & Rehabilitation Training & Research Hospital; University of Health Sciences Turkey; Istanbul Medeniyet UniversitySpasticity is the most common motor disturbance in cerebral palsy (CP). Lockdown in the COVID-19 outbreak has profoundly changed daily routines, and similarly caused the suspension of spasticity treatment plans. Besides, the delay in botulinum toxin (BoNT) injection, which is important in the management of focal spasticity, led to some problems in children. This consensus report includes BoNT injection recommendations in the management of spasticity during the COVID-19 pandemic in children with CP. In order to develop the consensus report, physical medicine and rehabilitation (PMR) specialists experienced in the field of pediatric rehabilitation and BoNT injections were invited by Pediatric Rehabilitation Association. Items were prepared and adapted to the Delphi technique by PMR specialists. Then they were asked to the physicians experienced in BoNT injections (PMR specialist, pediatric orthopedists, and pediatric neurologists) or COVID-19 (pediatric infectious disease, adult infectious disease). In conclusion, the experts agree that conservative management approaches for spasticity may be the initial steps before BoNT injections. BoNT injections can be administered to children with CP with appropriate indications and with necessary precautions during the pandemic.